Posted by piblogger on October 27, 2010 · Comments Off
No sooner does the news break that pharmaceutical giant GlaxoSmithKline deliberately withheld critical data which revealed that their diabetes drug Avandia significantly increased the risk of heart attacks amongst its largest users – senior citizens, today we received word that the company is paying $750 million to settle criminal and civil complaints linked to the … Read more
Posted by piblogger on October 27, 2010 · Comments Off
As you already know, there is no shortage of newsworthy information that crosses my virtual (and even physical) desk on a daily basis. When combined with my undeniably insatiable curiosity, this usually means that I could spend 25 hours a day and 8 days per week writing, or on the radio talking with a notable … Read more
Being Fined for Illegal Acts All A Part of Doing Business in the Pharmaceutical Industry
Posted by piblogger on October 27, 2010 · Comments Off
No sooner does the news break that pharmaceutical giant GlaxoSmithKline deliberately withheld critical data which revealed that their diabetes drug Avandia significantly increased the risk of heart attacks amongst its largest users – senior citizens, today we received word that the company is paying $750 million to settle criminal and civil complaints linked to the … Read more
Rate this:
Filed under Commentary/Article, Health Care & Medicine · Tagged with Angelo Mozilo, antidepressant drugs, AstraZeneca, Avandia, Johnson & Johnson, SmithGlaxoKline, tainted baby ointment